Skip to main content
EMC Instytut Medyczny S.A. logo

EMC Instytut Medyczny S.A. — Investor Relations & Filings

Ticker · EMC ISIN · PLEMCIM00017 LEI · 2594005WSYZ0JRE8U796 WAR Human health and social work activities
Open in API
Filings indexed 786 across all filing types
Latest filing 2025-07-29 Delisting Announcement
Country PL Poland
Listing WAR EMC

About EMC Instytut Medyczny S.A.

https://www.emc-sa.pl/en

EMC Instytut Medyczny S.A. is a significant operator of private hospitals and outpatient clinics. The company provides comprehensive healthcare services through a network of medical facilities. Its operations are structured into three primary segments: Hospital Care, Outpatient Care, and Clinical Trials. The company offers a wide range of medical specializations, including dermatology, gastroenterology, and immunology. In addition to its core patient care services, EMC Instytut Medyczny is also actively engaged in conducting clinical research.

Recent filings

Filing Released Lang Actions
Wydanie przez KNF zezwolenia na wycofanie akcji EMC Instytut Medyczny S.A. z obrotu na rynku regulowanym prowadzonym przez GPW oraz złożenie wniosku do GPW o wycofanie akcji z obrotu giełdowego - C...
Delisting Announcement Classification · 100% confidence The document is an official announcement from EMC Instytut Medyczny S.A. regarding the decision by the Polish Financial Supervision Authority (KNF) to delist the company's shares from the Warsaw Stock Exchange (GPW). It specifies the exact date of delisting (August 8, 2025) and the cessation of periodic reporting obligations. This fits the definition of a Delisting Announcement (DLST).
2025-07-29 Polish
Powiadomienie o transakcji - Aneta Łuczak
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically the Vice President of the Management Board, Aneta Łuczak. It explicitly references Article 19(1) of the Market Abuse Regulation (MAR). The content details the acquisition of shares under an incentive program. This falls under the category of Director's Dealing (DIRS), which covers insider trades and transactions by company executives.
2025-07-28 Polish
Powiadomienie o transakcji - Dariusz Chowaniec
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically the Vice President of the Management Board (Wiceprezes Zarządu), Dariusz Chowaniec, at EMC INSTYTUT MEDYCZNY S.A. It explicitly references Article 19(1) of the MAR (Market Abuse Regulation) and details the acquisition of shares under an incentive program. This falls directly under the category of Director's Dealing (DIRS).
2025-07-28 Polish
Powiadomienie o transakcji - Michał John
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically the Vice President of the Management Board, Michał John. It explicitly references Article 19(1) of the Market Abuse Regulation (MAR). This type of disclosure, where an executive reports their personal share-related transactions (in this case, accepting an offer for new series shares under an incentive program), is classified as a Director's Dealing.
2025-07-28 Polish
Powiadomienie o transakcji - Marcin Fakadej
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically the Vice President of the Management Board (Wiceprezes Zarządu), Marcin Fakadej. It explicitly references Article 19(1) of the Market Abuse Regulation (MAR). This type of disclosure, detailing the acquisition of shares by an insider, is classified as a Director's Dealing report.
2025-07-28 Polish
Powiadomienie o transakcji - Karol Piasecki
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically the CEO (Prezes Zarządu) of EMC Instytut Medyczny S.A. It explicitly references Article 19(1) of the Market Abuse Regulation (MAR). This type of disclosure, involving an insider's acquisition of shares (in this case, via an incentive program), is classified as a Director's Dealing.
2025-07-28 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.